Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Lanthier

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
World Journal of Hepatology|September 18, 2015
Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?Nicolas Lanthier
Clinics and Research in Hepatology and Gastroenterology|June 16, 2025
Does the benefit of optimal MASH treatment depend on a reduction in myosteatosis?Nicolas Lanthier
Cells|September 9, 2022
Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?Nicolas Lanthier, Nathalie Delzenne
European Journal of Clinical Investigation|May 19, 2017
Treatment of severe alcoholic hepatitis: past, present and futureNicolas Lanthier, Peter Stärkel
Clinics and Research in Hepatology and Gastroenterology|March 18, 2019
Resident liver progenitor cells: Proofs of their contribution to human liver regenerationNicolas Lanthier, Laurent Spahr
Clinics and Research in Hepatology and Gastroenterology|March 5, 2025
Macrophage therapy and liver regeneration: Results and perspectivesNicolas Lanthier, Laurent Spahr
Liver International : Official Journal of the International Association for the Study of the Liver|May 23, 2026
What Can We Learn From Longitudinal Measurements of Liver Stiffness in Metabolic Dysfunction-Associated Steatotic Liver Disease?Stéphanie André-Dumont, Nicolas Lanthier
Best Practice & Research. Clinical Gastroenterology|September 8, 2014
Adipose tissues as endocrine target organsNicolas Lanthier, Isabelle A Leclercq
Clinical Science (London, England : 1979)|August 22, 2020
Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatmentsFrédéric Clarembeau, Georgia Bale, Nicolas Lanthier
Clinics and Research in Hepatology and Gastroenterology|June 4, 2021
Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?Nicolas Lanthier, Peter Stärkel, Géraldine Dahlqvist
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
World Journal of Hepatology|September 18, 2015
Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?Nicolas Lanthier
Clinics and Research in Hepatology and Gastroenterology|June 16, 2025
Does the benefit of optimal MASH treatment depend on a reduction in myosteatosis?Nicolas Lanthier
Cells|September 9, 2022
Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?Nicolas Lanthier, Nathalie Delzenne
European Journal of Clinical Investigation|May 19, 2017
Treatment of severe alcoholic hepatitis: past, present and futureNicolas Lanthier, Peter Stärkel
Clinics and Research in Hepatology and Gastroenterology|March 18, 2019
Resident liver progenitor cells: Proofs of their contribution to human liver regenerationNicolas Lanthier, Laurent Spahr
Clinics and Research in Hepatology and Gastroenterology|March 5, 2025
Macrophage therapy and liver regeneration: Results and perspectivesNicolas Lanthier, Laurent Spahr
Liver International : Official Journal of the International Association for the Study of the Liver|May 23, 2026
What Can We Learn From Longitudinal Measurements of Liver Stiffness in Metabolic Dysfunction-Associated Steatotic Liver Disease?Stéphanie André-Dumont, Nicolas Lanthier
Best Practice & Research. Clinical Gastroenterology|September 8, 2014
Adipose tissues as endocrine target organsNicolas Lanthier, Isabelle A Leclercq
Clinical Science (London, England : 1979)|August 22, 2020
Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatmentsFrédéric Clarembeau, Georgia Bale, Nicolas Lanthier
Clinics and Research in Hepatology and Gastroenterology|June 4, 2021
Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?Nicolas Lanthier, Peter Stärkel, Géraldine Dahlqvist
Pageof 8